Suven Pharmaceuticals Limited (SUVENPHAR.NS)
INR 1222.2
(-1.95%)
INR 1222.2
(-1.95%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.12 Billion INR | -45.38% |
| 2022 | 7.54 Billion INR | 2.75% |
| 2021 | 7.34 Billion INR | 31.26% |
| 2020 | 5.59 Billion INR | 16.05% |
| 2019 | 4.82 Billion INR | 124.27% |
| 2018 | 2.15 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 809.9 Million INR | 6.52% |
| 2023 Q4 | 760.36 Million INR | -33.7% |
| 2023 Q3 | 1.14 Billion INR | -20.46% |
| 2023 Q1 | 2.14 Billion INR | 0.73% |
| 2023 Q2 | 1.44 Billion INR | -32.63% |
| 2023 FY | 4.12 Billion INR | -45.38% |
| 2022 Q1 | 1.99 Billion INR | 1.76% |
| 2022 Q4 | 2.12 Billion INR | 7.97% |
| 2022 Q3 | 1.96 Billion INR | 34.51% |
| 2022 Q2 | 1.46 Billion INR | -26.64% |
| 2022 FY | 7.54 Billion INR | 2.75% |
| 2021 Q1 | 1.48 Billion INR | 36.13% |
| 2021 Q2 | 1.64 Billion INR | 11.11% |
| 2021 Q4 | 1.95 Billion INR | -13.25% |
| 2021 Q3 | 2.25 Billion INR | 37.17% |
| 2021 FY | 7.34 Billion INR | 31.26% |
| 2020 Q3 | 1.73 Billion INR | 29.2% |
| 2020 FY | 5.59 Billion INR | 16.05% |
| 2020 Q2 | 1.34 Billion INR | -6.64% |
| 2020 Q1 | 1.43 Billion INR | 61.62% |
| 2020 Q4 | 1.08 Billion INR | -37.15% |
| 2019 Q3 | 1.07 Billion INR | -30.63% |
| 2019 Q4 | 888.46 Million INR | -17.59% |
| 2019 FY | 4.82 Billion INR | 124.27% |
| 2019 Q2 | 1.55 Billion INR | 18.54% |
| 2019 Q1 | 1.31 Billion INR | -8.04% |
| 2018 Q3 | 725.14 Million INR | 0.0% |
| 2018 Q4 | 1.42 Billion INR | 96.59% |
| 2018 FY | 2.15 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -105.929% |
| Ind-Swift Limited | 2.17 Billion INR | -89.791% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -180.151% |
| Sakar Healthcare Limited | 699.58 Million INR | -489.389% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 96.236% |
| Innova Captab Limited | 3.46 Billion INR | -19.017% |
| Divi's Laboratories Limited | 32.44 Billion INR | 87.29% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 33.738% |
| Morepen Laboratories Limited | 6.16 Billion INR | 33.078% |
| Mankind Pharma Limited | 42.19 Billion INR | 90.229% |
| Sequent Scientific Limited | 2.97 Billion INR | -38.424% |
| Wanbury Limited | 1.73 Billion INR | -138.251% |
| Laurus Labs Limited | 15.44 Billion INR | 73.31% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 14.513% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 66.836% |
| Alembic Limited | 1 Billion INR | -312.283% |
| Hikal Limited | 5.95 Billion INR | 30.794% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 84.604% |
| Neuland Laboratories Limited | 8.24 Billion INR | 50.008% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 72.978% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 94.054% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | 12.626% |
| Themis Medicare Limited | 2.42 Billion INR | -70.383% |
| RPG Life Sciences Limited | 2.48 Billion INR | -66.06% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 96.707% |
| Lupin Limited | 125.09 Billion INR | 96.704% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -96.905% |
| Wockhardt Limited | 7.72 Billion INR | 46.59% |
| Vaishali Pharma Limited | 90.32 Million INR | -4465.032% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 29.291% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -531.832% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 79.009% |
| FDC Limited | 6.58 Billion INR | 37.395% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 97.48% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -564.533% |
| Eris Lifesciences Limited | 10.42 Billion INR | 60.455% |
| Venus Remedies Limited | 2.18 Billion INR | -88.917% |
| ZIM Laboratories Limited | 1.26 Billion INR | -225.227% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -11.578% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -679.247% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 55.213% |
| Shilpa Medicare Limited | 3.56 Billion INR | -15.761% |
| Albert David Limited | 1.4 Billion INR | -192.828% |
| Ajanta Pharma Limited | 21.06 Billion INR | 80.425% |
| Hester Biosciences Limited | 1.27 Billion INR | -223.737% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 349.005% |
| Gufic Biosciences Limited | 4.07 Billion INR | -1.216% |
| Windlas Biotech Limited | 1.33 Billion INR | -207.983% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 28.68% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -3547.979% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -496.545% |
| Granules India Limited | 16.79 Billion INR | 75.456% |
| Aarti Drugs Limited | 8.31 Billion INR | 50.419% |
| Bal Pharma Limited | 770.19 Million INR | -435.355% |
| Alkem Laboratories Limited | 52.29 Billion INR | 92.116% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 98.405% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -118.525% |
| Medicamen Biotech Limited | 495.49 Million INR | -732.152% |
| Unichem Laboratories Limited | 4.86 Billion INR | 15.245% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -811.92% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -32767.868% |
| Valiant Laboratories Limited | 138.02 Million INR | -2887.252% |
| Orchid Pharma Limited | 2.32 Billion INR | -77.704% |
| Medico Remedies Limited | 262.14 Million INR | -1472.904% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | 0.241% |
| Ipca Laboratories Limited | 48.58 Billion INR | 91.513% |
| Brooks Laboratories Limited | 65.62 Million INR | -6183.563% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -636.953% |
| Piramal Enterprises Limited | 8.04 Billion INR | 48.737% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 91.182% |
| NATCO Pharma Limited | 25.73 Billion INR | 83.979% |
| Suven Life Sciences Limited | -200.79 Million INR | 2153.454% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 3891.621% |
| Strides Pharma Science Limited | 14.38 Billion INR | 71.342% |
| Indoco Remedies Limited | 8.04 Billion INR | 48.735% |
| Alpa Laboratories Limited | 188.89 Million INR | -2082.839% |
| Lasa Supergenerics Limited | 121.02 Million INR | -3306.82% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -954.368% |